ReviewBiodesign research2025
Protein design drives synthetic biology research of plant natural products.
Review in Biodesign research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plant natural products (PNPs) are widely used in pharmaceutical, cosmetic, and food industries. Currently, their commercial supply largely relies on plant extraction, yet, suffers from low yield and limited resources. Synthetic biology provides a promising solution by reconstituting biosynthetic pathways of PNPs in microbial systems. However, unknown enzymatic steps or poor functional performance of plant-derived enzymes often make it particularly challenging for the PNPs production in microorganisms. To address these limitations, much progress has been made in enzyme mining, enzymatic mechanism elucidation, and enzyme optimization by protein design technologies. The deep integration of artificial intelligence and synthetic biology has provided attractive solutions for the sustainable production of PNPs. This review introduces the cutting-edge advances of protein design technologies in PNPs biosynthesis, elaborates on the approaches to resolve the main bottlenecks in PNPs biosynthesis, and discusses the immense application potential driven by the integration of AI and synthetic biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.